# BAG6

## Overview
BAG6, or BCL2-associated athanogene 6, is a gene located within the human major histocompatibility complex (MHC) III region on chromosome 6. It encodes the multifunctional protein BAG cochaperone 6, which is involved in various cellular processes, including protein quality control, apoptosis regulation, and immune response. The protein is characterized by distinct domains, such as an N-terminal ubiquitin-like domain and a C-terminal BAG-similar domain, which facilitate its interactions with other proteins, including HSP70 chaperones and components of the proteasome (Binici2013BAG6; Kuwabara2015Structure). BAG6 plays a crucial role in the endoplasmic reticulum-associated degradation (ERAD) pathway, aiding in the degradation of misfolded proteins, and is involved in antigen presentation on MHC class I molecules, which is vital for immune surveillance (Minami2010BAG6; Benarroch2019The). Additionally, BAG6 is implicated in apoptosis regulation and has been associated with various diseases, including cancer and autoimmune disorders, due to its regulatory functions in cellular homeostasis and immune responses (Benarroch2019The).

## Structure
BAG6 (BCL2-associated athanogene 6) is a multifunctional protein with a complex molecular structure. It is encoded by a gene located in the human major histocompatibility complex (MHC) III region on chromosome 6 and exists in two major isoforms of 1,132 and 1,126 amino acids due to alternative splicing (Binici2013BAG6). The protein contains several distinct domains, including an N-terminal ubiquitin-like (UBL) domain, a long proline-rich stretch, and a C-terminal BAG domain (Binici2013BAG6).

The UBL domain is involved in protein degradation, while the BAG domain interacts with HSP70 chaperones (Binici2013BAG6). The C-terminal domain of BAG6, previously thought to be a canonical BAG domain, is structurally distinct and is now identified as a BAG-similar (BAGS) domain, which interacts with the TUGS domain of Ubl4a (Kuwabara2015Structure). This interaction involves a four-α-helix bundle formed by the crossing of α-helices from both proteins (Kuwabara2015Structure).

BAG6 forms a heterodimer with Ubl4a, and the complex is characterized by a tight binding with a dissociation constant of 2.2 nM (Kuwabara2015Structure). The secondary structure of the BAGS domain is largely unstructured in its monomeric form but becomes more helical upon binding with Ubl4a (Kuwabara2015Structure). BAG6 also forms a hetero-trimeric complex with TRC35 and Ubl4a, which is involved in tail-anchored protein targeting (Mock2017Structural). The protein's cellular localization and function can be regulated by post-translational modifications such as phosphorylation and interactions with other proteins like TRC35 (Binici2013BAG6; Mock2017Structural).

## Function
BAG6 (BAG cochaperone 6) is a multifunctional protein that plays a critical role in several cellular processes, including protein quality control, apoptosis regulation, and immune response. It is involved in the endoplasmic reticulum-associated degradation (ERAD) pathway, where it facilitates the degradation of misfolded or mislocalized proteins by directing them to the proteasome for degradation (Benarroch2019The). BAG6 forms a heterotrimeric complex with UBL4A and TRC35, enhancing its efficiency in maintaining protein homeostasis and preventing protein aggregation by stabilizing proteins in an unfolded state (Benarroch2019The).

BAG6 also plays a significant role in the immune system by influencing antigen presentation. It is involved in the degradation of defective ribosome products (DRiPs) and mislocalized proteins, contributing to the presentation of antigens on MHC class I molecules, which is crucial for immune surveillance (Minami2010BAG6). BAG6's expression is regulated by interferon-γ, which enhances its role in antigen presentation (Benarroch2019The).

In apoptosis regulation, BAG6 interacts with apoptosis-inducing proteins, such as Reaper, to inhibit apoptosis by affecting protein synthesis, which is vital in various cell systems, including cancer cells (Benarroch2019The).

## Clinical Significance
Mutations and alterations in the BAG6 gene are associated with several diseases and conditions. Single nucleotide polymorphisms (SNPs) in BAG6, such as rs3117582, have been linked to an increased risk of non-small cell lung cancer and osteoarthritis. The C allele of this SNP is associated with a higher risk of lung cancer, while variations in alleles affect susceptibility to osteoarthritis (Benarroch2019The; Etokebe2014Susceptibility). BAG6 polymorphisms are also connected to autoimmune diseases, including Kawasaki syndrome and type I diabetes, due to its role in immune regulation and T-cell response modulation (Benarroch2019The).

Alterations in BAG6 expression can lead to severe cellular abnormalities. Overexpression of BAG6 may result in the earlier onset of autoimmune diseases by promoting helper T-cell responses (Benarroch2019The). In the context of cancer, increased nuclear levels of BAG6 have been associated with tumorigenesis, particularly in osteosarcoma tissue (Benarroch2019The). BAG6 is also implicated in mitochondrial quality control and autophagy, processes critical in neurodegenerative disorders and cancer. Its role in mitophagy involves the PINK1/PARKIN signaling pathway, and mutations affecting this function can impair mitochondrial degradation (Ragimbeau2021BAG6).

## Interactions
BAG6, also known as BCL2-associated athanogene 6, is involved in various protein interactions, playing a significant role in protein quality control and degradation. It interacts with the 26S proteasome, facilitating the degradation of defective proteasomal substrates by acting as a tethering factor for polyubiquitinated proteins (Minami2010BAG6). BAG6 forms a complex with Ubl4a and TRC35, which is crucial for tail-anchored protein biogenesis, maintaining newly synthesized proteins in an unfolded state before their insertion into the endoplasmic reticulum membrane (Binici2013BAG6; Kuwabara2015Structure).

BAG6 also interacts with Hsp70, suggesting a role in the metabolism of misfolded proteins (Minami2010BAG6). It is part of a multiprotein complex that includes Ubl4A and TRC35, which chaperones retrotranslocated polypeptides for proteasomal degradation (Binici2013BAG6). BAG6's interaction with TRC35 is mediated by specific structural interfaces, and it acts as a chaperone holdase in protein quality control processes (Mock2017Structural).

In the context of immune responses, BAG6 is involved in the presentation of MHC class I molecules and interacts with components of the immune system, such as natural killer cells, influencing their activity (Minami2010BAG6; Binici2013BAG6).


## References


[1. (Minami2010BAG6) Ryosuke Minami, Atsuko Hayakawa, Hiroki Kagawa, Yuko Yanagi, Hideyoshi Yokosawa, and Hiroyuki Kawahara. Bag-6 is essential for selective elimination of defective proteasomal substrates. Journal of Cell Biology, 190(4):637–650, August 2010. URL: http://dx.doi.org/10.1083/jcb.200908092, doi:10.1083/jcb.200908092. This article has 115 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1083/jcb.200908092)

[2. (Ragimbeau2021BAG6) Romain Ragimbeau, Leila El Kebriti, Salwa Sebti, Elise Fourgous, Abdelhay Boulahtouf, Giuseppe Arena, Lucile Espert, Andrei Turtoi, Céline Gongora, Nadine Houédé, and Sophie Pattingre. Bag6 promotes pink1 signaling pathway and is essential for mitophagy. The FASEB Journal, January 2021. URL: http://dx.doi.org/10.1096/fj.202000930r, doi:10.1096/fj.202000930r. This article has 16 citations.](https://doi.org/10.1096/fj.202000930r)

[3. (Binici2013BAG6) Janina Binici and Joachim Koch. Bag-6, a jack of all trades in health and disease. Cellular and Molecular Life Sciences, 71(10):1829–1837, December 2013. URL: http://dx.doi.org/10.1007/s00018-013-1522-y, doi:10.1007/s00018-013-1522-y. This article has 51 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-013-1522-y)

[4. (Etokebe2014Susceptibility) Godfrey E. Etokebe, Zdravko Jotanovic, Radovan Mihelic, Biserka Mulac‐Jericevic, Tamara Nikolic, Sanja Balen, Branko Sestan, and Zlatko Dembic. Susceptibility to large‐joint osteoarthritis (hip and knee) is associated with bag6 rs3117582 snp and the vntr polymorphism in the second exon of the fam46a gene on chromosome 6. Journal of Orthopaedic Research, 33(1):56–62, September 2014. URL: http://dx.doi.org/10.1002/jor.22738, doi:10.1002/jor.22738. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/jor.22738)

[5. (Benarroch2019The) Rashi Benarroch, Jennifer M. Austin, Fahmeda Ahmed, and Rivka L. Isaacson. The roles of cytosolic quality control proteins, SGTA and the BAG6 complex, in disease, pages 265–313. Elsevier, 2019. URL: http://dx.doi.org/10.1016/bs.apcsb.2018.11.002, doi:10.1016/bs.apcsb.2018.11.002. This article has 24 citations.](https://doi.org/10.1016/bs.apcsb.2018.11.002)

[6. (Kuwabara2015Structure) Naoyuki Kuwabara, Ryosuke Minami, Naoto Yokota, Hirofumi Matsumoto, Toshiya Senda, Hiroyuki Kawahara, and Ryuichi Kato. Structure of a bag6 (bcl-2-associated athanogene 6)-ubl4a (ubiquitin-like protein 4a) complex reveals a novel binding interface that functions in tail-anchored protein biogenesis. Journal of Biological Chemistry, 290(15):9387–9398, April 2015. URL: http://dx.doi.org/10.1074/jbc.m114.631804, doi:10.1074/jbc.m114.631804. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m114.631804)

[7. (Mock2017Structural) Jee-Young Mock, Yue Xu, Yihong Ye, and William M. Clemons. Structural basis for regulation of the nucleo-cytoplasmic distribution of bag6 by trc35. Proceedings of the National Academy of Sciences, 114(44):11679–11684, October 2017. URL: http://dx.doi.org/10.1073/pnas.1702940114, doi:10.1073/pnas.1702940114. This article has 23 citations.](https://doi.org/10.1073/pnas.1702940114)